abnormal urine homeostasis_Aga<tm1Vk>/Aga<tm1Vk>

http://metadb.riken.jp/0009643I129S1Sv129X1SvJBlackSwissAgatm1VkAgatm1VkAgatm1Vk

abnormal urine homeostasis_Aga<tm1Vk>/Aga<tm1Vk>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• aspartylglucosaminidase
  http://metadb.riken.jp/db/mgi_rdf/MGI:104873

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Aga<tm1Vk>/Aga<tm1Vk>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Aga<tm1Vk>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * 129X1/SvJ * Black Swiss

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal urine homeostasis
  http://purl.obolibrary.org/obo/MP_0009643

文献

http://purl.org/net/cito/citesAsAuthority

• U. Dunder, et.al., Enzyme replacement therapy in a mouse model of aspartylglycosaminuria., FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2000, 14
  http://rdf.ncbi.nlm.nih.gov/pubmed/10657992
• V. Kaartinen, et.al., A mouse model for the human lysosomal disease aspartylglycosaminuria., Nature medicine, 1996, 2
  http://rdf.ncbi.nlm.nih.gov/pubmed/8946839